These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 25884624)
1. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth. Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA‑518b functions as a tumor suppressor in glioblastoma by targeting PDGFRB. Xu X; Zhang F; Chen X; Ying Q Mol Med Rep; 2017 Oct; 16(4):5326-5332. PubMed ID: 28849154 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity. Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681 [TBL] [Abstract][Full Text] [Related]
4. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
5. Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway. Nitta RT; Gholamin S; Feroze AH; Agarwal M; Cheshier SH; Mitra SS; Li G Oncogene; 2015 Jul; 34(28):3688-99. PubMed ID: 25241897 [TBL] [Abstract][Full Text] [Related]
6. Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance. Tran AN; Walker K; Harrison DG; Chen W; Mobley J; Hocevar L; Hackney JR; Sedaka RS; Pollock JS; Goldberg MS; Hambardzumyan D; Cooper SJ; Gillespie Y; Hjelmeland AB Neuro Oncol; 2018 Jul; 20(8):1055-1067. PubMed ID: 29409010 [TBL] [Abstract][Full Text] [Related]
7. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma. Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259 [TBL] [Abstract][Full Text] [Related]
8. RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1. Yu H; Zhang S; Ibrahim AN; Wang J; Deng Z; Wang M Biochem Biophys Res Commun; 2019 Aug; 516(3):999-1006. PubMed ID: 31277942 [TBL] [Abstract][Full Text] [Related]
9. Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma. Correa BR; de Araujo PR; Qiao M; Burns SC; Chen C; Schlegel R; Agarwal S; Galante PA; Penalva LO Genome Biol; 2016 Jun; 17(1):125. PubMed ID: 27287018 [TBL] [Abstract][Full Text] [Related]
10. Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma. Wang J; Zuo J; Wang M; Ma X; Gao K; Bai X; Wang N; Xie W; Liu H Oncol Rep; 2019 Apr; 41(4):2159-2167. PubMed ID: 30816483 [TBL] [Abstract][Full Text] [Related]
12. Sprouty2 enhances the tumorigenic potential of glioblastoma cells. Park JW; Wollmann G; Urbiola C; Fogli B; Florio T; Geley S; Klimaschewski L Neuro Oncol; 2018 Jul; 20(8):1044-1054. PubMed ID: 29635363 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells. Zhang S; Lai N; Liao K; Sun J; Lin Y Folia Neuropathol; 2015; 53(3):236-44. PubMed ID: 26443314 [TBL] [Abstract][Full Text] [Related]
14. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2. Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992 [TBL] [Abstract][Full Text] [Related]
15. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal. Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223 [TBL] [Abstract][Full Text] [Related]
16. E2F transcription factor 8 promotes proliferation and radioresistance in glioblastoma. Yu H; Zhang D; Li Z; Wang M Pathol Res Pract; 2020 Aug; 216(8):153030. PubMed ID: 32703494 [TBL] [Abstract][Full Text] [Related]
17. The mechanisms of malic enzyme 2 in the tumorigenesis of human gliomas. Cheng CP; Huang LC; Chang YL; Hsieh CH; Huang SM; Hueng DY Oncotarget; 2016 Jul; 7(27):41460-41472. PubMed ID: 27166188 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome. Bai Y; Zhang QG; Wang XH Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217 [TBL] [Abstract][Full Text] [Related]
19. Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells. Lamballe F; Toscano S; Conti F; Arechederra M; Baeza N; Figarella-Branger D; Helmbacher F; Maina F Oncotarget; 2016 Nov; 7(46):74747-74767. PubMed ID: 27732969 [TBL] [Abstract][Full Text] [Related]